Nil Hocaoğlu1, Nergis Murat2, Serap Cilaker Mıcılı3, Burç Aydın2, Bekir Uğur Ergür3, Şule Kalkan1. 1. Division of Clinical Toxicology, Department of Pharmacology, Dokuz Eylül University School of Medicine, İzmir, Turkey. 2. Department of Pharmacology, Dokuz Eylül University School of Medicine, İzmir, Turkey. 3. Deparment of Histology and Embryology, Dokuz Eylül University School of Medicine, İzmir, Turkey.
Abstract
BACKGROUND: Amitriptyline is an important cause of mortality due to its cardiovascular toxicity. AIMS: To investigate the changes in levels of cardiac S100b protein on amitriptyline-induced cardiotoxicity and also to examine the correlation between amitriptyline-induced cardiotoxic effects and cardiac S100b protein in an isolated rat heart model. STUDY DESIGN: Animal experimentation, isolated heart model. METHODS: After a stabilization period, isolated hearts were randomized to two groups (n=5 and n=7). In the control group, isolated hearts were subjected to an infusion of 5% dextrose for 60 minutes. In the amitriptyline group, 5.5×10-5 M amitriptyline was infused for 60 minutes to achieve amitriptyline toxicity. After the infusion period, heart tissues were removed for histological examination. RESULTS: In comparison to control treatment, amitriptyline infusion decreased left ventricular developed pressure (LVDP), dp/dtmax and heart rate (HR) and significantly prolonged QRS duration (p<0.05). The semiquantitative scores for S100b protein levels in amitriptyline-infused hearts were higher than in the control group (p<0.01). At the end of the experiment, in the amitriptyline-infused group, significant correlations were found between LVDP and S100b protein scores (r=-0.807, p=0.003) and between QRS duration and S100b protein scores (r=0.859, p=0.001). CONCLUSION: Our results indicate that the S100b protein may be a helpful indicator or biomarker in studying the cardiotoxic effects of amitriptyline.
BACKGROUND:Amitriptyline is an important cause of mortality due to its cardiovascular toxicity. AIMS: To investigate the changes in levels of cardiac S100b protein on amitriptyline-induced cardiotoxicity and also to examine the correlation between amitriptyline-induced cardiotoxic effects and cardiac S100b protein in an isolated rat heart model. STUDY DESIGN: Animal experimentation, isolated heart model. METHODS: After a stabilization period, isolated hearts were randomized to two groups (n=5 and n=7). In the control group, isolated hearts were subjected to an infusion of 5% dextrose for 60 minutes. In the amitriptyline group, 5.5×10-5 M amitriptyline was infused for 60 minutes to achieve amitriptylinetoxicity. After the infusion period, heart tissues were removed for histological examination. RESULTS: In comparison to control treatment, amitriptyline infusion decreased left ventricular developed pressure (LVDP), dp/dtmax and heart rate (HR) and significantly prolonged QRS duration (p<0.05). The semiquantitative scores for S100b protein levels in amitriptyline-infused hearts were higher than in the control group (p<0.01). At the end of the experiment, in the amitriptyline-infused group, significant correlations were found between LVDP and S100b protein scores (r=-0.807, p=0.003) and between QRS duration and S100b protein scores (r=0.859, p=0.001). CONCLUSION: Our results indicate that the S100b protein may be a helpful indicator or biomarker in studying the cardiotoxic effects of amitriptyline.
Authors: Wim Jan P van Boven; Aurora Morariu; Sacha P Salzberg; Wim B Gerritsen; Frans G Waanders; Tiny C Korse; Leon P Aarts Journal: Innovations (Phila) Date: 2013 May-Jun
Authors: S Di Legge; V Di Piero; F Di Stani; R Perna; R Gattuso; M G Reale; F Benedetti Valentini; G L Lenzi Journal: Neurol Sci Date: 2003-12 Impact factor: 3.307
Authors: Funda Tüzün; Pınar Gencpınar; Seda Ozbal; Mustafa Dilek; Bekir Ugur Ergur; Nuray Duman; Hasan Ozkan; Abdullah Kumral Journal: Neurosci Lett Date: 2012-05-08 Impact factor: 3.046
Authors: Nicholas A Buckley; Stephan Chevalier; I Anne Leditschke; Dianne L O'Connell; James Leitch; Susan M Pond Journal: Crit Care Date: 2003-08-18 Impact factor: 9.097